Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphoma.
Jia B, Shi Y, Kang S, Yang S, Hu S, Li Y, Dong M, Wang W, Yang J, Zhou L, Liu P, Zhou S, Qin Y, Gui L, Zhang C, Lin H, Chen S, Wang L, He X.
Jia B, et al.
Chin J Cancer Res. 2015 Oct;27(5):516-23. doi: 10.3978/j.issn.1000-9604.2015.10.04.
Chin J Cancer Res. 2015.
PMID: 26543339
Free PMC article.